Edition:
United States

Acceleron Pharma Inc (XLRN.OQ)

XLRN.OQ on NASDAQ Stock Exchange Global Market

48.39USD
17 Aug 2018
Change (% chg)

-- (--)
Prev Close
$48.39
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
121,645
52-wk High
$50.00
52-wk Low
$32.48

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.67 December 20 Aug 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 3 3 3 3
(2) OUTPERFORM 4 5 8 8
(3) HOLD 5 5 2 2
(4) UNDERPERFORM 0 0 1 1
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.17 2.15 2.07 2.07

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-18 10 4.26 9.50 2.50 3.80
Quarter Ending Dec-18 10 7.02 28.74 3.00 3.93
Year Ending Dec-18 11 17.75 39.22 12.60 38.90
Year Ending Dec-19 12 65.48 170.19 17.50 99.77
Earnings (per share)
Quarter Ending Sep-18 13 -0.67 -0.57 -0.82 -0.70
Quarter Ending Dec-18 13 -0.66 -0.31 -1.04 -0.71
Year Ending Dec-18 13 -2.55 -2.26 -3.07 -2.24
Year Ending Dec-19 13 -1.93 -0.30 -3.39 -0.97

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Jun-18 3.80 3.68 0.11 2.97
Quarter Ending Mar-18 4.21 3.23 0.98 23.22
Quarter Ending Dec-17 3.60 3.70 0.10 2.90
Quarter Ending Sep-17 4.98 3.01 1.97 39.50
Quarter Ending Jun-17 3.69 3.06 0.64 17.21
Earnings (per share)
Quarter Ending Jun-18 -0.64 -0.63 0.01 -2.14
Quarter Ending Mar-18 -0.64 -0.58 0.06 -9.88
Quarter Ending Dec-17 -0.61 -0.62 0.01 -2.29
Quarter Ending Sep-17 -0.64 -0.65 0.01 -1.61
Quarter Ending Jun-17 -0.62 -0.68 0.06 -8.80

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-18 4.26 4.21 6.77 6.77 3.80
Quarter Ending Dec-18 7.02 6.97 10.63 10.63 3.93
Year Ending Dec-18 17.75 19.66 25.02 26.05 38.90
Year Ending Dec-19 65.48 65.20 65.70 67.83 99.77
Earnings (per share)
Quarter Ending Sep-18 -0.67 -0.66 -0.62 -0.60 -0.70
Quarter Ending Dec-18 -0.66 -0.65 -0.58 -0.55 -0.71
Year Ending Dec-18 -2.55 -2.53 -2.42 -2.35 -2.24
Year Ending Dec-19 -1.93 -1.96 -1.90 -1.85 -0.97

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-18 1 0 3 3
Quarter Ending Dec-18 1 0 3 4
Year Ending Dec-18 1 0 5 5
Year Ending Dec-19 1 0 7 1
Earnings
Quarter Ending Sep-18 1 1 5 8
Quarter Ending Dec-18 1 1 5 7
Year Ending Dec-18 1 1 5 8
Year Ending Dec-19 2 0 8 4